Assessment of FDA-approved drugs against Strongyloides ratti in vitro and in vivo to identify potentially active drugs against strongyloidiasis

被引：0
|
作者：
Jennifer Keiser
Cécile Häberli
机构：
[1] Swiss Tropical and Public Health Institute,Department of Medical Parasitology and Infection Biology
[2] University of Basel,undefined
来源：
Parasites & Vectors | / 14卷
关键词：
FDA library; Drug discovery; In vitro; In vivo;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Assessment of FDA-approved drugs against Strongyloides ratti in vitro and in vivo to identify potentially active drugs against strongyloidiasis
    Keiser, Jennifer
    Haeberli, Cecile
    PARASITES & VECTORS, 2021, 14 (01)
  • [2] Repurposing of FDA-approved drugs against cancer - focus on metastasis
    Ozsvari, Bela
    Lamb, Rebecca
    Lisanti, Michael P.
    AGING-US, 2016, 8 (04): : 567 - 568
  • [3] Scientists Repurposing FDA-Approved Drugs to Fight against Viruses
    YAN Fusheng
    BulletinoftheChineseAcademyofSciences, 2019, 33 (03) : 187 - 188
  • [4] In vitro and in silico investigation of FDA-approved drugs to be repurposed against Alzheimer's disease
    Akkaya, Didem
    Seyhan, Gokce
    Sari, Suat
    Barut, Burak
    DRUG DEVELOPMENT RESEARCH, 2024, 85 (03)
  • [5] Repurposing FDA-approved drugs against the toxicity of platinum-based anticancer drugs
    Famurewa, Ademola C.
    Mukherjee, Anirban Goutam
    Wanjari, Uddesh Ramesh
    Sukumar, Aarthi
    Murali, Reshma
    Renu, Kaviyarasi
    Vellingiri, Balachandar
    Dey, Abhijit
    Gopalakrishnan, Abilash Valsala
    LIFE SCIENCES, 2022, 305
  • [6] Combinatory effect of fluconazole and FDA-approved drugs against Candida albicans
    Kaneko, Yukihiro
    Fukazawa, Hidesuke
    Ohno, Hideaki
    Miyazaki, Yoshitsugu
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2013, 19 (06) : 1141 - 1145
  • [7] The Repurposing of FDA-Approved Drugs as FtsZ Inhibitors against Mycobacterium tuberculosis: An In Silico and In Vitro Study
    Tovar-Nieto, Andrea Michel
    Flores-Padilla, Luis Enrique
    Rivas-Santiago, Bruno
    Trujillo-Paez, Juan Valentin
    Lara-Ramirez, Edgar Eduardo
    Jacobo-Delgado, Yolanda M.
    Lopez-Ramos, Juan Ernesto
    Rodriguez-Carlos, Adrian
    MICROORGANISMS, 2024, 12 (08)
  • [8] Onchocerciasis Drug Discovery: In Vitro Evaluation of FDA-Approved Drugs against Onchocerca gutturosa in Gambia
    Gokool, Suzanne
    Townson, Simon
    Freeman, Andrew
    Siemienski-Kleyn, Jadzia
    Zubrzycki, Jakub
    Tagboto, Senyo
    Huebner, Marc P.
    Scandale, Ivan
    PHARMACEUTICS, 2024, 16 (02)
  • [9] Screening of an FDA-Approved Library for Novel Drugs against Y. pestis
    Gur, David
    Chitlaru, Theodor
    Mamroud, Emanuelle
    Zauberman, Ayelet
    ANTIBIOTICS-BASEL, 2021, 10 (01): : 1 - 8
  • [10] Investigations of an FDA-approved compound library for potential drugs against Schistosoma mansoni
    Panic, G.
    Vargas, M.
    Scandale, I.
    Keiser, J.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2015, 20 : 235 - 236
12345